Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Document › Details

Bruker Corporation. (12/21/22). "Press Release: Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference". Billerica, MA.

Region Region San Francisco, CA
  Country United States (USA)
Organisations Organisation Bruker Corporation (Nasdaq: BRKR)
  Group Bruker (Group)
  Organisation 2 J.P. Morgan Securities LLC
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 41st Annual Healthcare Conference 2023 San Francisco
  Product 2 analytical instrument
Index term Index term Bruker–JPMorgan Chase: investor conference, 202301 supply service Bruker presents at JP Morgan Healthcare Conference 2023
Persons Person Laukien, Frank H. (Bruker 201204 President + CEO)
  Person 2 Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel)
     


Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 41st annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 9th, 2023 at 10:30 AM Eastern Standard Time.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.


About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.


Investors:

Justin Ward
Senior Director, Investor Relations & Corporate Development
+1 (978) 663-3660 x1479
Investor.Relations@bruker.com

   
Record changed: 2023-06-05

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Bruker (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top